EI- Nile Co. for Pharmaceuticals and Chemical Industries (EGX:NIPH)

EGX:NIPH Cash Flow Statement

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Net Income	60.88	90.23	119.21	89.67	64.42	93.38
Depreciation & Amortization	-1	-	330.18	-	-	-
Other Operating Activities	157.27	173.89	-705.83	-84.76	15.05	-43.72
Operating Cash Flow	217.15	264.11	-256.43	4.91	79.47	49.66
Operating Cash Flow Growth	60226.62%	-	-	-93.82%	60.02%	-31.22%
Capital Expenditures	-595.66	-419.69	-27.63	-48.74	-4.38	-5.14
Sale of Property, Plant & Equipment	-	-	-	0.62	-	-
Investment in Securities	-	-	-	-	-	-0.7
Other Investing Activities	0.13	0.1	0.12	0.12	0.09	0.06
Investing Cash Flow	-595.53	-419.58	-27.52	-48	-4.29	-5.77
Short-Term Debt Issued	-	92.37	135.02	20.68	0.37	-
Long-Term Debt Issued	-	304.77	179.22	-	-	8.48
Total Debt Issued	619.13	397.14	314.23	20.68	0.37	8.48
Long-Term Debt Repaid	-	-29.4	-121.1	-	-	-
Net Debt Issued (Repaid)	512.78	367.74	193.13	20.68	0.37	8.48
Common Dividends Paid	-64.51	-64.38	-41.66	-33.3	-45.57	-
Other Financing Activities	-	-	121.1	-	-	-
Financing Cash Flow	448.27	303.36	272.57	-12.62	-45.2	8.48
Net Cash Flow	69.9	147.89	-11.38	-55.71	29.99	52.37
Free Cash Flow	-378.51	-155.57	-284.07	-43.83	75.09	44.53
Free Cash Flow Growth	-	-	-	-	68.64%	-36.85%
Free Cash Flow Margin	-38.95%	-13.62%	-28.26%	-5.00%	9.94%	5.48%
Free Cash Flow Per Share	-37.38	-15.37	-28.06	-4.33	7.42	-
Cash Interest Paid	79.54	39.65	27.16	2.89	3.18	5.04
Cash Income Tax Paid	47.75	52.98	69.42	45.08	32.77	26.73
Levered Free Cash Flow	-341.66	-232.04	189.36	-77.9	39.66	12.57
Unlevered Free Cash Flow	-319.39	-216.22	197.94	-75.92	41.96	15.89
Change in Net Working Capital	-199.36	-113.77	206.34	105.58	13.42	51.72

Source: S&P Global Market Intelligence. Standard template. Financial Sources.